4//SEC Filing
Coelho Mary Theresa 4
Accession 0001103021-21-000018
CIK 0001103021other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 7:12 PM ET
Size
9.2 KB
Accession
0001103021-21-000018
Insider Transaction Report
Form 4
Coelho Mary Theresa
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-01-29+10,190→ 34,079 total - Sale
Common Stock
2021-02-01$3.87/sh−3,460$13,390→ 30,619 total - Exercise/Conversion
Restricted Stock Units
2021-01-29−10,190→ 20,381 totalExercise: $0.00Exp: 2023-01-29→ Common Stock (10,190 underlying)
Footnotes (3)
- [F1]The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan.
- [F2]On February 1, 2021, the Reporting Person sold an aggregate of 3,460 shares of the Issuer's Common Stock at a weighted average price of $3.87 per share. The highest sale price for the Common Stock was $3.89 per share and the lowest sale price was $3.87 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
- [F3]The shares of common stock were acquired by the Reporting Person as a result of the vesting of 10,190 Restricted Stock Units ("RSUs") granted to the Reporting Person on January 29, 2020 under the Issuer's 2019 Stock Option Incentive Plan, as amended. The remainder of the RSUs under this grant will vest in equal portions on January 29, 2022 and January 29, 2023.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001720772
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 7:12 PM ET
- Size
- 9.2 KB